Beschreibung
InhaltsangabeSection I:Principles and challenges of MDCT / Introduction-I.1.MDCT:Technical principles and future trends-I.2.Contrast medium administration and scan timing for MDCT Section II:Abdominal imaging / Introduction-II.1.Imaging benign and metastatic liver tumors with MDCT-II.2.MDCT of primary liver malignancy-II.3.MDCT of the pancreas-II.4.Abdominal imaging:Use of high concentration contrast media Section III:Cardiac and vascular imaging / Introduction-III.1.Essentials of contrast medium delivery for CT angiography-III.2.Current and future indications of cardiac MDCT-III.3.Abdominal aorta, renal arteries and run-off vessels-III.4.MDCT for diagnosis of pulmonary embolism: Have we reached our goal? Section IV:Future prospects in MDCT imaging / Introduction-IV.1.Interventional MDCT-IV.2.Functional CT imaging in stroke and oncology-IV.3.MDCT and data explosion: current technologies and directions for future development in managing the information overload-IV.4.Late adverse events following administration of iodinated contrast media: an update
Autorenportrait
InhaltsangabeSection I:Principles and challenges of MDCT / Introduction-I.1.MDCT:Technical principles and future trends-I.2.Contrast medium administration and scan timing for MDCT Section II:Abdominal imaging / Introduction-II.1.Imaging benign and metastatic liver tumors with MDCT-II.2.MDCT of primary liver malignancy-II.3.MDCT of the pancreas-II.4.Abdominal imaging:Use of high concentration contrast media Section III:Cardiac and vascular imaging / Introduction-III.1.Essentials of contrast medium delivery for CT angiography-III.2.Current and future indications of cardiac MDCT-III.3.Abdominal aorta, renal arteries and run-off vessels-III.4.MDCT for diagnosis of pulmonary embolism: Have we reached our goal? Section IV:Future prospects in MDCT imaging / Introduction-IV.1.Interventional MDCT-IV.2.Functional CT imaging in stroke and oncology-IV.3.MDCT and data explosion: current technologies and directions for future development in managing the information overload-IV.4.Late adverse events following administration of iodinated contrast media: an update
Informationen gemäß Produktsicherheitsverordnung
Hersteller:
Springer Verlag GmbH
juergen.hartmann@springer.com
Tiergartenstr. 17
DE 69121 Heidelberg
